John G. Teeter

1.3k total citations
29 papers, 874 citations indexed

About

John G. Teeter is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Hematology. According to data from OpenAlex, John G. Teeter has authored 29 papers receiving a total of 874 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 9 papers in Physiology and 8 papers in Hematology. Recurrent topics in John G. Teeter's work include Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers), Asthma and respiratory diseases (9 papers) and Inhalation and Respiratory Drug Delivery (8 papers). John G. Teeter is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers), Asthma and respiratory diseases (9 papers) and Inhalation and Respiratory Drug Delivery (8 papers). John G. Teeter collaborates with scholars based in United States, Canada and South Africa. John G. Teeter's co-authors include Eugene R. Bleecker, Carl Shanholtz, Roy G. Brower, Peter White, Steven Piantadosi, Jeffrey M. Dodd‐o, Yaniv Almog, H Fessler, Charles Wiener and David Shade and has published in prestigious journals such as Blood, The Journal of Clinical Endocrinology & Metabolism and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

John G. Teeter

29 papers receiving 838 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John G. Teeter United States 12 709 233 164 117 97 29 874
James M. Goff United States 15 399 0.6× 129 0.6× 103 0.6× 77 0.7× 98 1.0× 36 797
In‐Kyung Song South Korea 14 265 0.4× 47 0.2× 65 0.4× 123 1.1× 57 0.6× 72 772
Sean M. Bailey United States 16 349 0.5× 150 0.6× 69 0.4× 60 0.5× 120 1.2× 44 1.1k
Patrick J. Neligan Ireland 11 189 0.3× 114 0.5× 132 0.8× 101 0.9× 58 0.6× 23 553
John Fuller Canada 14 165 0.2× 75 0.3× 85 0.5× 64 0.5× 59 0.6× 27 668
Javid Sadjadi United States 19 161 0.2× 100 0.4× 230 1.4× 76 0.6× 54 0.6× 39 828
Jens Geiseler Germany 16 1.1k 1.5× 239 1.0× 129 0.8× 350 3.0× 48 0.5× 51 1.4k
Catherine Farrow Australia 11 330 0.5× 174 0.7× 655 4.0× 192 1.6× 201 2.1× 27 1.0k
Matthias Böck Germany 15 165 0.2× 122 0.5× 63 0.4× 265 2.3× 27 0.3× 43 781
Frank Lally United Kingdom 12 135 0.2× 119 0.5× 35 0.2× 22 0.2× 163 1.7× 20 668

Countries citing papers authored by John G. Teeter

Since Specialization
Citations

This map shows the geographic impact of John G. Teeter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John G. Teeter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John G. Teeter more than expected).

Fields of papers citing papers by John G. Teeter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John G. Teeter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John G. Teeter. The network helps show where John G. Teeter may publish in the future.

Co-authorship network of co-authors of John G. Teeter

This figure shows the co-authorship network connecting the top 25 collaborators of John G. Teeter. A scholar is included among the top collaborators of John G. Teeter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John G. Teeter. John G. Teeter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matino, Davide, Andrew Palladino, Carrie Turich Taylor, et al.. (2025). Marstacimab prophylaxis in hemophilia A/B without inhibitors: results from the phase 3 BASIS trial. Blood. 146(14). 1654–1663. 3 indexed citations
2.
Kazani, Shamsah, Travis J. Gould, Peng Sun, et al.. (2025). Sustained Efficacy of Marstacimab in Adults and Adolescents with Severe Hemophilia A or B without Inhibitors. Hämostaseologie. 45. 1 indexed citations
3.
4.
5.
Pasquale, Margaret K., Yihua Xu, Christine L. Baker, et al.. (2016). COPD exacerbations associated with the modified Medical Research Council scale and COPD assessment test among Humana Medicare members. International Journal of COPD. 11. 111–111. 10 indexed citations
6.
Hassoun, Paul M., Sylvia Nikkho, Erika B. Rosenzweig, et al.. (2013). Updating Clinical Endpoint Definitions. Pulmonary Circulation. 3(1). 206–216. 17 indexed citations
7.
Dai, Haiqing, et al.. (2012). The pharmacokinetics and pharmacodynamics of PF-00734200, a DPP-IV inhibitor, in healthy Japanese subjects. International Journal of Clinical Pharmacology and Therapeutics. 50(7). 505–509. 2 indexed citations
8.
Mendivil, Carlos O., John G. Teeter, Gregory L. Finch, et al.. (2011). Trough Insulin Levels in Bronchoalveolar Lavage Following Inhaled Human Insulin (Exubera) in Patients with Diabetes Mellitus. Diabetes Technology & Therapeutics. 14(1). 50–58. 4 indexed citations
9.
Hegewald, Matthew, Robert L. Jensen, John G. Teeter, et al.. (2011). Long-Term Intersession Variability for Single-Breath Diffusing Capacity. Respiration. 84(5). 377–384. 5 indexed citations
10.
Terra, Steven G., Veena Somayaji, S. Schwartz, et al.. (2011). A Dose-Ranging Study of the DPP-IV Inhibitor PF-734200 Added to Metformin in Subjects With Type 2 Diabetes. Experimental and Clinical Endocrinology & Diabetes. 119(7). 401–407. 7 indexed citations
11.
Rosenstock, Julio, Andrew Lewin, Paul Norwood, et al.. (2010). Efficacy and safety of the dipeptidyl peptidase-4 inhibitor PF-734200 added to metformin in Type 2 diabetes. Diabetic Medicine. 28(4). 464–469. 10 indexed citations
12.
Drummond, Michael, Pamela F. Schwartz, William Duggan, et al.. (2008). Intersession Variability in Single-Breath Diffusing Capacity in Diabetics without Overt Lung Disease. American Journal of Respiratory and Critical Care Medicine. 178(3). 225–232. 17 indexed citations
13.
Cefalu, William T., Nancy J.V. Bohannon, S Edwin Fineberg, et al.. (2008). Assessment of long-term immunological and pulmonary safety of inhaled human insulin with up to 24 months of continuous therapy. Current Medical Research and Opinion. 24(11). 3073–3083. 1 indexed citations
14.
Fountaine, Robert J., Greg C. G. Wei, Marilyn Stolar, et al.. (2008). Acute passive cigarette smoke exposure and inhaled human insulin (Exubera®) pharmacokinetics. British Journal of Clinical Pharmacology. 65(6). 864–870. 7 indexed citations
15.
Riese, Richard J., et al.. (2008). Effects of inhaled human insulin on airway lining fluid composition in adults with diabetes. European Respiratory Journal. 32(1). 180–188. 14 indexed citations
16.
Jensen, Robert L., et al.. (2007). Sources of Long-term Variability in Measurements of Lung Function. CHEST Journal. 132(2). 396–402. 41 indexed citations
17.
Jensen, Robert L., et al.. (2007). Instrument Accuracy and Reproducibility in Measurements of Pulmonary Function. CHEST Journal. 132(2). 388–395. 41 indexed citations
18.
Wise, Robert A., John G. Teeter, Robert L. Jensen, et al.. (2007). Standardization of the Single-Breath Diffusing Capacity in a Multicenter Clinical Trial. CHEST Journal. 132(4). 1191–1197. 28 indexed citations
19.
Brower, Roy G., Carl Shanholtz, H Fessler, et al.. (1999). Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients. Critical Care Medicine. 27(8). 1492–1498. 346 indexed citations
20.
Teeter, John G., et al.. (1997). Asthma Training in Third-Year Medical Students. Journal of Asthma. 34(5). 379–386. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James M. Goff Breakdown of academic impact, for papers by In‐Kyung Song Breakdown of academic impact, for papers by Sean M. Bailey Breakdown of academic impact, for papers by Patrick J. Neligan Breakdown of academic impact, for papers by John Fuller Breakdown of academic impact, for papers by Javid Sadjadi Breakdown of academic impact, for papers by Jens Geiseler Breakdown of academic impact, for papers by Catherine Farrow Breakdown of academic impact, for papers by Matthias Böck Breakdown of academic impact, for papers by Frank Lally
Rankless by CCL
2026